| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |